InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (12 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
12
T+90 hit rate
50%
T+90 mean return
+1.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Grossman Adam S, Chief Executive Officer. Insider active across 1 company, notably Adma Biologics, INC.. Aggregated, 62 reports have been logged. Breakdown: 2 buys · 12 sells. Total volume traded: €13.1m. History available since 29 September 2021. The latest transaction was filed on 16 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Grossman Adam S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations62 total
15,000 shares@ US$5.400.0037% mcap0.3% of flowCommon StockSEC:0001140361-26-009899:0
15,000 shares@ US$15.160.010% mcap0.9% of flowCommon StockSEC:0001140361-26-009899:1
6,000 shares@ US$15.160.0041% mcap0.3% of flowCommon StockSEC:0001140361-26-009899:2
56,438 shares@ US$15.390.039% mcap3.3% of flowCommon StockSEC:0001140361-26-008904:0
29,513 shares@ US$15.390.020% mcap1.7% of flowCommon StockSEC:0001140361-26-008904:1
54,858 shares@ US$15.182.9% of flowCommon StockSEC:0001140361-26-007406:0
24,793 shares@ US$16.321.4% of flowCommon StockSEC:0001140361-26-006461:0
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-26-005888:0
15,000 shares@ US$16.080.9% of flowCommon StockSEC:0001140361-26-005888:1
6,000 shares@ US$16.080.4% of flowCommon StockSEC:0001140361-26-005888:2
282,529 shares0Common StockSEC:0001140361-26-004890:0
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-045737:0
15,000 shares@ US$19.791.1% of flowCommon StockSEC:0001140361-25-045737:1
6,000 shares@ US$19.790.4% of flowCommon StockSEC:0001140361-25-045737:2
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-042997:0
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-039331:0
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-035159:0
15,000 shares@ US$16.130.9% of flowCommon StockSEC:0001140361-25-035159:1
6,000 shares@ US$16.130.4% of flowCommon StockSEC:0001140361-25-035159:2
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-031601:0
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-026099:0
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-023017:0
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-019589:0
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-014267:0
15,000 shares@ US$5.400.3% of flowCommon StockSEC:0001140361-25-009928:0
25 of 62 declarations
About Grossman Adam S
Grossman Adam S is Président et Directeur Général and is associated with Adma Biologics, INC. on XNAS. He has 62 filings, and across the sampled recent filings from 2021-10-01 to 2026-03-17, buy amounts total EUR 126700 and sell amounts total EUR 12924361, with Retenue fiscale as the most frequent transaction nature.
